The device, OKV-119, is a GLP-1 implant, or a small device inserted under the skin that can deliver doses of medication for ...

A California pharmaceutical company is preparing to test a new weight-loss medication designed specifically for overweight ...

A clinical study into weight loss drugs for pets just launched, with results from the trial expected by next summer.

Recent estimates suggest that about 60% of the nation’s cats and dogs have obesity; hundreds of thousands of cats and dogs ...

Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...

Some veterinarians are already prescribing GLP-1 drugs intended for humans to pets, with one veterinary endocrinologist at ...

Instead of weekly injections like humans receive, the cats in the study will get small injectable implants, slightly larger ...

Obesity isn’t just a human problem; around 60% of cats and dogs in the U.S. are considered overweight or obese. Now, a new ...

ORLANDO, Fla. — Okava Pharmaceuticals has launched a pilot program testing GLP-1 injections for obese cats, according to a ...

Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to the FDA for approval as a weight-management treatment ...

This One Habit Could Be Quietly Shortening Your Cat’s Life originally appeared on PetHelpful. In the past, cats weren't nearly as obese as they are now because they were outside all of the time, or at ...